Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Analytical Chemistry >  Standard >  Pharmaceutical Impurity Reference Standards >  N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture)

N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture)

Basic information Safety Supplier Related

N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture) Basic information

Product Name:
N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture)
Synonyms:
  • 4-[1-[4-[2-(methylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]phenol
  • 4OHNDtam
  • E/Z Endoxifen
  • N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture)
  • 4-hydroxy-N-desmethyltamoxifen
  • 4-[(E)-1-[4-(2-methylaminoethoxy)phenyl]-2-phenyl-but-1-enyl]phenol
  • 4-[(Z)-1-[4-[2-(Methylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]phenol
  • N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture) see H938500
CAS:
110025-28-0
MF:
C25H27NO2
MW:
373.49
Product Categories:
  • Aromatics
  • Intermediates & Fine Chemicals
  • Metabolites & Impurities
  • Pharmaceuticals
Mol File:
110025-28-0.mol
More
Less

N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture) Chemical Properties

Melting point:
63-72°C
Boiling point:
519.3±50.0 °C(Predicted)
Density 
1.099±0.06 g/cm3(Predicted)
storage temp. 
-20°C Freezer
solubility 
Chloroform, Dichloromethane, DMSO, Methanol
form 
Solid
pka
9.38±0.15(Predicted)
color 
Light Brown to Light Purple
InChI
InChI=1S/C25H27NO2/c1-3-24(19-7-5-4-6-8-19)25(20-9-13-22(27)14-10-20)21-11-15-23(16-12-21)28-18-17-26-2/h4-16,26-27H,3,17-18H2,1-2H3
InChIKey
MHJBZVSGOZTKRH-UHFFFAOYSA-N
SMILES
C1(O)=CC=C(C(C2=CC=C(OCCNC)C=C2)=C(C2=CC=CC=C2)CC)C=C1
More
Less

N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture) Usage And Synthesis

Chemical Properties

Brown Foam

Uses

A novel active metabolite of the anti-cancer drug Tamoxifen. It showed potent ER binding property, blocked estrogen stimulated growth of breast cancer cell and half maximal inhibition of estrogen responsive gene expression in ER pos. human breast ca

Uses

A novel active metabolite of the anti-cancer drug Tamoxifen (T006000). It showed potent ER binding property, blocked estrogen stimulated growth of breast cancer cell and half maximal inhibition of estrogen responsive gene expression in ER pos. human breast cancer cell line.

in vivo

Orally administered Endoxifen is rapidly absorbed and systemically available when tested in female rats. The Endoxifen-treated rats show 787% higher exposure (AUC0–∞) and 1,500% higher concentration (Cmax) levels of Endoxifen when compared with Tamoxifen. Oral Endoxifen administration once a day for 28 consecutive days at dosages 2, 4, and 8 mg/kg proves safe and results in progressive inhibition of the growth of the human mammary tumor xenografts in female mice[2].

IC 50

Aromatase; ERα

storage

Store at +4°C

N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture)Supplier

Beijing LAL Pharmaceutical Co., Ltd. Gold
Tel
010-010-62452898 13581984929
Email
jlzhang929@163.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Email
info@chemlin.com.cn
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
BOC Sciences
Tel
16314854226
Email
info@bocsci.com